Naquotinib Uses, Dosage, Side Effects and more
Naquotinib has been used in trials studying the treatment of Solid Tumors, Non-small Cell Lung Cancer, Non-Small-Cell Lung Cancer (NSCLC), Epidermal Growth Factor Receptor Mutations, and Epidermal Growth Factor Receptor (EGFR) Mutations, among others.
| Trade Name | Naquotinib |
| Generic | Naquotinib |
| Naquotinib Other Names | Naquotinib |
| Type | |
| Formula | C30H42N8O3 |
| Weight | Average: 562.719 Monoisotopic: 562.337987244 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
